Morgan Keegan Raises HAE Target From $65 To $70

Morgan Keegan is raising its PT on Haemonetics Corporation HAE from $65 to $70.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst Ratingshaemonetics corporationHealth CareHealth Care SuppliesMorgan Keegan
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!